Our manufacturing expertise and experience differentiates us from other microbiome companies. We manufacture a single strain, as opposed to a consortium, which allows for simpler testing and release processes. We know the biological activity of our strain making potency testing reliable and repeatable. We have been producing commercial scale cosmetic product for several years and have been able to optimize our process and protocols over time. We use the same manufacturing process to make our clinical products which are currently used in our clinical studies. To date, we have made over 140,000 bottles with timelines associated with fulfilling consumer demand as well as the demands of clinical supply. We have scaled up to 50 liter cultures for our last successful clinical trial and will be supplying our upcoming Phase 3 trials from 100 liter scale. The company continues to invest in its manufacturing capabilities, including facilities, team and intellectual property.